Yüklüyor......
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder characterized by motor as well as nonmotor symptoms for which there is currently no cure. The Q175 mouse model of HD recapitulates many of the symptoms identified in HD patients including disruptions of the sleep/wak...
Kaydedildi:
| Yayımlandı: | Pharmacol Res Perspect |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5625154/ https://ncbi.nlm.nih.gov/pubmed/28971617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.344 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|